Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 923093 STAMFORD, CT

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
15 quarters on record

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Jun 30, 2026
CallValue
$7,981,312
CallShares
12,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,981,312 12,800
2026-03-31 $540,848 700
2025-12-31 $19,682,685 25,500
2025-12-31 $40,291,614 52,200
2025-09-30 $23,615,340 42,000
2025-09-30 $16,643,192 29,600
2025-06-30 $14,962,500 28,500
2025-06-30 $44,388,750 84,550
2025-06-30 $18,217,500 34,700
2025-03-31 $21,056,436 33,200
2025-03-31 $79,971,963 126,093
2025-03-31 $11,099,025 17,500
2024-12-31 $7,123,300 10,000
2024-12-31 $12,821,940 18,000
2024-12-31 $20,351,268 28,570
2024-09-30 $7,884,300 7,500
2024-09-30 $3,258,844 3,100
2024-09-30 $39,580,237 37,651
2023-09-30 $4,772,345 5,799
2023-06-30 $9,805,196 13,646
2023-03-31 $2,524,170 3,072
2022-12-31 $2,607,464 3,614
2022-06-30 $999,009 1,690
2021-06-30 $888,637 1,591
2020-03-31 $1,184,591 2,426